Countries Malaysia
Bioeconomy Set to Make Malaysia’s Economic Recovery Plans Robust
“We have the Bioeconomy Blueprint – set to launch in the third quarter of 2021 – that establishes the direction of Malaysia’s bio...
June 22, 2021 | News
Malaysia Granted Permission for COVID-19 Test Kit from China for Emergency Use
Amid rising concerns about the threat and economic impact of COVID-19, Holista Colltech Limited has been granted permission for Special access under the Me...
June 18, 2021 | News
Malaysia Healthcare & LifeScience review
Risk & Reward Index Industry Rewards 44.4 Industry Risk 80.9 Regional Rank 08 ...
June 17, 2021 | Analysis
CarePool Asia - Malaysia first telehealth platform that offers unlimited consultation service
CAREPOOL ASIA, an innovative digital health platform launches its new, affordable digital health packages, the first telehealth platform that offers u...
June 16, 2021 | News
BookDoc Seeks Strategic Partnerships for Expansion Plan
BookDoc, an award-winning company currently present in 5 countries (Malaysia, Singapore, Indonesia, Hong Kong and Thailand) and 20...
June 15, 2021 | News
IN3BIO gains approval for Phase I/II clinical trial
IN3BIO will trial its innovative anti-EGF vaccine IN01, in combination with small molecule inhibitors (SMIs) in patients suffering from KRAS or NRAS (...
June 10, 2021 | News
Arctic Vision Announces the Treatment of Dry Eye Disease
iTEAR®100 is an FDA-cleared external neurostimulation device that increases acute tear production. Arctic Vision, a clinical stage biotech company foc...
June 07, 2021 | News
Mobile vaccination trucks to be activated in Kuala Lumpur
The National Covid-19 Immunisation Programme Coordinating Minister said the pilot mobile vaccination truck project will be implemented by the Federal Terri...
May 31, 2021 | News
Malaysia's Healthcare Sector: An ASEAN Rising Giant
Malaysia operates an internationally lauded healthcare system, fueled by investments in world-class facilities and quality human resources. The country ...
May 31, 2021 | Analysis
Most COVID-19 Patients Have Long-term Neurological Problems
In a surprise, however, a research team at NYU Grossman School of Medicine also found that 91 percent of patients, whether or not they had a neurological d...
May 25, 2021 | Analysis
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
